Literature DB >> 17711526

Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study.

E Alpsoy1, L Donmez, M Onder, S Gunasti, A Usta, Y Karincaoglu, B Kandi, S Buyukkara, O Keseroglu, S Uzun, U Tursen, M Seyhan, A Akman.   

Abstract

BACKGROUND: Behçet's disease (BD) is a systemic inflammatory disease with unpredictable exacerbations and remissions. The natural course of BD is not fully known.
OBJECTIVES: We aimed retrospectively to determine the occurrence of the symptoms in chronological order. We also evaluated the influence of the treatment and follow-up on the clinical severity and tried to identify the factors determining severe organ involvement.
METHODS: Six hundred and sixty-one patients were involved in this multicentre study. The symptoms of the disease were recorded retrospectively in the time order of the manifestations in each patient.
RESULTS: Oral ulcers were the most common manifestation (100%), followed by genital ulcers (85.3%), papulopustular lesions (55.4%), erythema nodosum (44.2%), skin pathergy reaction (37.8%), and articular (33.4%) and ocular involvement (29.2%). Oral ulcers were the most common onset manifestation (88.7%). The mean +/- SD duration between the onset symptom and the fulfilment of diagnostic criteria was calculated to be 4.3 +/- 5.7 years. The clinical severity score was significantly increased in the noncompliant treatment group compared with the compliant group with the passage of time (P < 0.001). The frequency of ocular involvement and genital ulcers was significantly higher in patients whose disease onset was at < 40 years. Genital ulcers, ocular involvement, papulopustular lesions, thrombophlebitis and skin pathergy reaction were found to be significantly more frequent in males.
CONCLUSIONS: Mucocutaneous lesions are the hallmarks of the disease, and especially oral ulcers precede other manifestations. The increase in clinical severity score is more pronounced in patients without regular treatment and follow-up. Male sex and a younger age at onset are associated with more severe disease.

Entities:  

Mesh:

Year:  2007        PMID: 17711526     DOI: 10.1111/j.1365-2133.2007.08116.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  43 in total

1.  A 44-year-old man with eye, kidney, and brain dysfunction.

Authors:  Ivana Vodopivec; Derek H Oakley; Cory A Perugino; Nagagopal Venna; E Tessa Hedley-Whyte; John H Stone
Journal:  Ann Neurol       Date:  2016-03-07       Impact factor: 10.422

Review 2.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

3.  Behçet's disease, painful genital ulcerations and steroid pulse therapy.

Authors:  T Aldeen
Journal:  BMJ Case Rep       Date:  2009-02-27

4.  Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Behçet's disease.

Authors:  Esra Erkol İnal; Aydın Rüstemoğlu; Ahmet İnanır; Duygu Ekinci; Ülker Gül; Serbülent Yiğit; Ömer Ateş
Journal:  Rheumatol Int       Date:  2014-11-06       Impact factor: 2.631

5.  Development of de novo major involvement during follow-up in Behçet's syndrome.

Authors:  Rosaria Talarico; Luca Cantarini; Anna d'Ascanio; Michele Figus; Benedetta Favati; Chiara Baldini; Chiara Tani; R Neri; Stefano Bombardieri; Marta Mosca
Journal:  Clin Rheumatol       Date:  2015-03-08       Impact factor: 2.980

Review 6.  Similarities and differences between Behçet's disease and Crohn's disease.

Authors:  Veli Yazısız
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

7.  Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.

Authors:  Jurgen Sota; Donato Rigante; Giacomo Emmi; Giuseppe Lopalco; Ida Orlando; Gian Marco Tosi; Bruno Frediani; Antonio Vitale; Silvana Guerriero; Florenzo Iannone; Lorenzo Vannozzi; Claudia Fabiani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2020-02-01       Impact factor: 3.397

Review 8.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

9.  Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis.

Authors:  S Yavuz; T Akdeniz; V Hancer; M Bicakcigil; M Can; G Yanikkaya-Demirel
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

10.  Renal amyloidosis in Behçet's disease: clinicopathologic features of 8 cases.

Authors:  Kemal Kosemehmetoglu; Dilek Ertoy Baydar
Journal:  Int Urol Nephrol       Date:  2012-09-09       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.